Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,586 | 94 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| DUSA Pharmaceuticals, Inc. | $301.90 | 3 | $0 (2018) |
| ABBVIE INC. | $214.33 | 17 | $0 (2022) |
| GENZYME CORPORATION | $168.46 | 8 | $0 (2019) |
| Regeneron Healthcare Solutions, Inc. | $125.71 | 7 | $0 (2019) |
| Lilly USA, LLC | $84.77 | 6 | $0 (2019) |
| PFIZER INC. | $83.57 | 7 | $0 (2020) |
| Janssen Biotech, Inc. | $68.78 | 6 | $0 (2019) |
| Genentech USA, Inc. | $50.97 | 4 | $0 (2019) |
| Biofrontera Inc. | $49.82 | 3 | $0 (2019) |
| Sun Pharmaceutical Industries Inc. | $45.85 | 3 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2022 | $13.80 | 1 | ABBVIE INC. ($13.80) |
| 2020 | $13.06 | 1 | PFIZER INC. ($13.06) |
| 2019 | $510.88 | 37 | AbbVie, Inc. ($124.92) |
| 2018 | $399.62 | 28 | GENZYME CORPORATION ($64.96) |
| 2017 | $648.41 | 27 | DUSA Pharmaceuticals, Inc. ($268.18) |
All Payment Transactions
94 individual payment records from CMS Open Payments — Page 1 of 4
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 03/08/2022 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $13.80 | General |
| Category: IMMUNOLOGY | ||||||
| 01/21/2020 | PFIZER INC. | EUCRISA (Drug) | Food and Beverage | In-kind items and services | $13.06 | General |
| Category: DERMATOLOGY | ||||||
| 11/19/2019 | AbbVie, Inc. | Skyrizi (Biological) | Food and Beverage | In-kind items and services | $14.63 | General |
| Category: Immunology | ||||||
| 11/19/2019 | AbbVie, Inc. | Skyrizi (Biological) | Food and Beverage | In-kind items and services | $9.58 | General |
| Category: Immunology | ||||||
| 11/06/2019 | Janssen Biotech, Inc. | Tremfya (Drug), STELARA | Food and Beverage | In-kind items and services | $12.17 | General |
| Category: Immunology | ||||||
| 11/05/2019 | PruGen, Inc. Pharmaceuticals | — | Food and Beverage | In-kind items and services | $5.61 | General |
| 11/05/2019 | PruGen, Inc. Pharmaceuticals | — | Food and Beverage | In-kind items and services | $4.31 | General |
| 10/22/2019 | Biofrontera Inc. | Ameluz (Drug), BF-RhodoLED, XEPI | Food and Beverage | Cash or cash equivalent | $15.28 | General |
| Category: Dermatology | ||||||
| 10/15/2019 | Almirall LLC | Cordran (Drug) | Food and Beverage | Cash or cash equivalent | $12.77 | General |
| Category: Dermatology | ||||||
| 10/10/2019 | GENZYME CORPORATION | DUPIXENT (Drug) | Food and Beverage | In-kind items and services | $23.61 | General |
| Category: IMMUNOLOGY | ||||||
| 10/01/2019 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $23.27 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 09/17/2019 | AbbVie, Inc. | Skyrizi (Biological), Humira | Food and Beverage | In-kind items and services | $18.98 | General |
| Category: Immunology | ||||||
| 08/13/2019 | GENZYME CORPORATION | DUPIXENT (Drug) | Food and Beverage | In-kind items and services | $24.85 | General |
| Category: IMMUNOLOGY | ||||||
| 07/25/2019 | Genentech USA, Inc. | Erivedge (Biological) | Food and Beverage | In-kind items and services | $13.03 | General |
| Category: BioOncology | ||||||
| 07/18/2019 | PFIZER INC. | EUCRISA (Drug) | Food and Beverage | In-kind items and services | $13.56 | General |
| Category: DERMATOLOGY | ||||||
| 07/16/2019 | AbbVie, Inc. | Humira (Biological), Skyrizi | Food and Beverage | In-kind items and services | $20.09 | General |
| Category: Immunology | ||||||
| 06/07/2019 | PruGen, Inc. Pharmaceuticals | — | Food and Beverage | In-kind items and services | $3.33 | General |
| 06/04/2019 | GENZYME CORPORATION | DUPIXENT (Drug) | Food and Beverage | In-kind items and services | $24.85 | General |
| Category: IMMUNOLOGY | ||||||
| 05/16/2019 | Genentech USA, Inc. | Xolair (Biological) | Food and Beverage | In-kind items and services | $14.88 | General |
| Category: Immunology | ||||||
| 05/02/2019 | AbbVie, Inc. | Skyrizi (Biological) | Food and Beverage | In-kind items and services | $21.32 | General |
| Category: Immunology | ||||||
| 05/01/2019 | AbbVie, Inc. | Humira (Biological) | Food and Beverage | In-kind items and services | $6.32 | General |
| Category: Immunology | ||||||
| 04/23/2019 | PruGen, Inc. Pharmaceuticals | — | Food and Beverage | In-kind items and services | $4.17 | General |
| 04/04/2019 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $17.35 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 04/03/2019 | Lilly USA, LLC | TALTZ (Drug) | Food and Beverage | In-kind items and services | $12.74 | General |
| Category: Immunology | ||||||
| 03/27/2019 | Ortho Dermatologics, a division of Bausch Health US, LLC | BRYHALI (Drug), SILIQ | Food and Beverage | In-kind items and services | $15.81 | General |
| Category: DERMATOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2021 | 15 | 1,777 | 2,150 | $210,180 | $106,599 |
| 2020 | 20 | 2,769 | 3,646 | $344,385 | $194,260 |
All Medicare Procedures & Services
35 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 578 | 623 | $61,995 | $33,185 | 53.5% |
| 17110 | Destruction of up to 14 skin growths | Office | 2021 | 337 | 366 | $44,115 | $26,404 | 59.9% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 291 | 328 | $46,210 | $22,773 | 49.3% |
| 17000 | Destruction of skin growth | Office | 2021 | 188 | 211 | $20,145 | $7,195 | 35.7% |
| 11102 | Tangential biopsy of single skin lesion | Office | 2021 | 56 | 56 | $6,990 | $3,171 | 45.4% |
| 99203 | New patient outpatient visit, total time 30-44 minutes | Office | 2021 | 42 | 42 | $5,265 | $2,559 | 48.6% |
| 99212 | Established patient outpatient visit, total time 10-19 minutes | Office | 2021 | 63 | 67 | $4,390 | $2,268 | 51.7% |
| 17261 | Destruction of malignant growth (0.6 to 1.0 centimeters) of trunk, arms, or legs | Office | 2021 | 19 | 20 | $3,000 | $1,837 | 61.2% |
| 11104 | Punch biopsy of single skin lesion | Office | 2021 | 18 | 18 | $2,790 | $1,613 | 57.8% |
| 17003 | Destruction of 2-14 skin growths | Office | 2021 | 104 | 334 | $6,730 | $1,530 | 22.7% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 19 | 19 | $3,230 | $1,352 | 41.8% |
| 11200 | Removal of up to and including 15 skin tags | Office | 2021 | 23 | 23 | $2,300 | $1,084 | 47.1% |
| 17111 | Destruction of 15 or more non-cancerous skin growths | Office | 2021 | 13 | 13 | $1,820 | $1,078 | 59.2% |
| 11900 | Injection of up to 7 skin growths | Office | 2021 | 13 | 15 | $1,125 | $536.62 | 47.7% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2021 | 13 | 15 | $75.00 | $14.67 | 19.6% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 1,050 | 1,197 | $144,990 | $86,577 | 59.7% |
| 17110 | Destruction of up to 14 skin growths | Office | 2020 | 492 | 542 | $65,300 | $42,555 | 65.2% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 260 | 299 | $27,135 | $14,968 | 55.2% |
| 17000 | Destruction of skin growth | Office | 2020 | 319 | 377 | $36,065 | $13,480 | 37.4% |
| 99203 | New patient office or other outpatient visit, typically 30 minutes | Office | 2020 | 83 | 83 | $10,110 | $6,236 | 61.7% |
| 17261 | Destruction of malignant growth (0.6 to 1.0 centimeters) of trunk, arms, or legs | Office | 2020 | 51 | 57 | $8,625 | $6,053 | 70.2% |
| 11102 | Tangential biopsy of single skin lesion | Office | 2020 | 88 | 92 | $11,530 | $5,822 | 50.5% |
| 17003 | Destruction of 2-14 skin growths | Office | 2020 | 193 | 738 | $14,800 | $3,314 | 22.4% |
| 17280 | Destruction of malignant growth (0.5 centimeters or less) of face, ears, eyelids, nose, lips, or mouth | Office | 2020 | 20 | 21 | $3,045 | $1,979 | 65.0% |
| 11104 | Punch biopsy of single skin lesion | Office | 2020 | 20 | 21 | $3,295 | $1,963 | 59.6% |
About Holly Shaffer
Holly Shaffer is a Dermatology healthcare provider based in Wilmington, North Carolina. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/21/2007. The National Provider Identifier (NPI) number assigned to this provider is 1952594178.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Holly Shaffer has received a total of $1,586 in payments from pharmaceutical and medical device companies, with $13.80 received in 2022. These payments were reported across 94 transactions from 25 companies. The most common payment nature is "Food and Beverage" ($1,586).
As a Medicare-enrolled provider, Shaffer has provided services to 4,546 Medicare beneficiaries, totaling 5,796 services with total Medicare billing of $300,859. Data is available for 2 years (2020–2021), covering 35 distinct procedure/service records.
Practice Information
- Specialty Dermatology
- Other Specialties Student in an Organized Health Care Education/Training Program
- Location Wilmington, NC
- Active Since 08/21/2007
- Last Updated 06/07/2013
- Taxonomy Code 207N00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1952594178
Products in Payments
- Levulan (Drug) $268.18
- DUPIXENT (Drug) $168.46
- Humira (Biological) $108.84
- TALTZ (Drug) $84.77
- EUCRISA (Drug) $83.57
- DUPIXENT DUPILUMAB INJECTION (Biological) $68.55
- Skyrizi (Biological) $64.51
- DUPIXENT (Biological) $57.16
- Ameluz (Drug) $49.82
- COSENTYX (Biological) $42.61
- Enbrel (Biological) $37.16
- Erivedge (Biological) $36.09
- Tremfya (Drug) $34.04
- Cimzia (Drug) $32.62
- Olux (Drug) $30.21
- ENSTILAR (Drug) $27.41
- STELARA (Biological) $23.69
- DORYX (Drug) $22.88
- Finacea (Drug) $19.52
- SILIQ (Drug) $17.90
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Dermatology Doctors in Wilmington
Rosalyn George, M.d, M.D
Dermatology — Payments: $417,485
Laura Tanner, M.d, M.D
Dermatology — Payments: $85,157
Mr. James Appel, M.d, M.D
Dermatology — Payments: $35,878
Dr. Aron Gewirtzman, M.d, M.D
Dermatology — Payments: $24,635
Dr. Michael Rosenthal, D.o, D.O
Dermatology — Payments: $21,448
Dr. Jonathan Crane, D.o, D.O
Dermatology — Payments: $12,737